Advantages and challenges of alternative sources of adult-derived stem cells for brain repair in stroke

Progress in Brain Research

Volumn 201, Issue , 2012, Pages 99-117

  Sanberg, Paul R ^a   Eve, David J ^a   Metcalf, Christopher ^a   Borlongan, Cesario V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adipose tissue; Breast milk; Induced pluripotent cells; Menstrual blood; Neural tissue; Teeth; Transplantation; Umbilical cord blood

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE CELL; ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST MILK; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; EXTRAEMBRYONIC TISSUE STEM CELL; FETAL STEM CELL; HUMAN; MENSTRUATION; MESENCHYMAL STROMA CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 84870223663     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59544-7.00006-8     Document Type: Chapter

References (116)

1. Ajmo C.T., Vernon D.O., Collier L., Hall A.A., Garbuzova-Davis S., Willing A., Pennypacker K.R. The spleen contributes to stroke-induced neurodegeneration. J. Neurosci. Res. 2008, 86:2227-2234.
2. Allickson J.G., Sanchez A., Yefimenko N., Borlongan C.V., Sanberg P.R. Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J. 2011, 3:4-10.
3. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., Toren A., Constantini S., Rechavi G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009, 6:e1000029.
4. Amariglio N., Rechavi G. On the origin of glioneural neoplasms after neural cell transplantation. Nat. Med. 2010, 16:157. author reply pp. 157-158.
5. Bachstetter A.D., Pabon M.M., Cole M.J., Hudson C.E., Sanberg P.R., Willing A.E., Bickford P.C., Gemma C. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci. 2008, 9:22.
6. Barkho B.Z., Munoz A.E., Li X., Li L., Cunningham L.A., Zhao X. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008, 26:3139-3149.
7. Barlow S., Brooke G., Chatterjee K., Price G., Pelekanos R., Rossetti T., Doody M., Venter D., Pain S., Gilshenan K., Atkinson K. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008, 17:1095-1107.
8. Boltze J., Reich D.M., Hau S., Reymann K.G., Strassburger M., Lobsien D., Wagner D.C., Kamprad M., Stahl T. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant. 2012, 21:723-737.
9. Borlongan C.V. Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke 2009, 40:S146-S148.
10. Borlongan C.V., Chopp M., Steinberg G.K., Bliss T.M., Li Y., Lu M., Hess D.C., Kondziolka D. Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen. Med. 2008, 3:249-250.
11. Borlongan C.V., Kaneko Y., Maki M., Yu S.J., Ali M., Allickson J.G., Sanberg C.D., Kuzmin-Nichols N., Sanberg P.R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev. 2010, 19:439-452.
12. Borlongan C.V., Weiss M.D. Baby STEPS: a giant leap for cell therapy in neonatal brain injury. Pediatr. Res. 2011, 70:3-9.
13. Breunig J.J., Arellano J.I., Macklis J.D., Rakic P. Everything that glitters isn't gold: a critical review of postnatal neural precursor analyses. Cell Stem Cell 2007, 1:612-627.
14. Burns T.C., Ortiz-Gonzalez X.R., Gutierrez-Perez M., Keene C.D., Sharda R., Demorest Z.L., Jiang Y., Nelson-Holte M., Soriano M., Nakagawa Y., Luquin M.R., Garcia-Verdugo J.M., Prosper F., Low W.C., Verfaillie C.M. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells 2006, 24:1121-1127.
15. Cai J., Li W., Su H., Qin D., Yang J., Zhu F., Xu J., He W., Guo X., Labuda K., Peterbauer A., Wolbank S., Zhong M., Li Z., Wu W., So K.F., Redl H., Zeng L., Esteban M.A., Pei D. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J. Biol. Chem. 2010, 285:11227-11234.
16. Carbajal K.S., Schaumburg C., Strieter R., Kane J., Lane T.E. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11068-11073.
17. Chaichana K.L., Guerrero-Cazares H., Capilla-Gonzalez V., Zamora-Berridi G., Achanta P., Gonzalez-Perez O., Jallo G.I., Garcia-Verdugo J.M., Quinones-Hinojosa A. Intra-operatively obtained human tissue: protocols and techniques for the study of neural stem cells. J. Neurosci. Methods 2009, 180:116-125.
18. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., Lu M., Gautam S.C., Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2003, 73:778-786.
19. Chen J., Li Y., Zhang R., Katakowski M., Gautam S.C., Xu Y., Lu M., Zhang Z., Chopp M. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res. 2004, 1005:21-28.
20. Chen J., Shehadah A., Pal A., Zacharek A., Cui X., Cui Y., Roberts C., Lu M., Zeitlin A., Hariri R., Chopp M. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant 2012, (in press).
21. Chin M.H., Mason M.J., Xie W., Volinia S., Singer M., Peterson C., Ambartsumyan G., Aimiuwu O., Richter L., Zhang J., Khvorostov I., Ott V., Grunstein M., Lavon N., Benvenisty N., Croce C.M., Clark A.T., Baxter T., Pyle A.D., Teitell M.A., Pelegrini M., Plath K., Lowry W.E. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009, 5:111-123.
22. Chopp M., Steinberg G.K., Kondziolka D., Lu M., Bliss T.M., Li Y., Hess D.C., Borlongan C.V. Who's in favor of translational cell therapy for stroke: STEPS forward please?. Cell Transplant. 2009, 18:691-693.
23. de la Fuente R., Bernad A., Garcia-Castro J., Martin M.C., Cigudosa J.C. Retraction: spontaneous human adult stem cell transformation. Cancer Res. 2010, 70:6682.
24. Deierborg T., Roybon L., Inacio A.R., Pesic J., Brundin P. Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes. Neuroscience 2010, 171:1386-1396.
25. Deierborg T., Staflin K., Pesic J., Roybon L., Brundin P., Lundberg C. Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries. Exp. Neurol. 2009, 219:363-367.
26. Deuse T., Stubbendorff M., Tang-Quan K., Phillips N., Kay M.A., Eiermann T., Phan T.T., Volk H.D., Reichenspurner H., Robbins R.C., Schrepfer S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 2011, 20:655-667.
27. Diaz-Prado S., Muinos-Lopez E., Hermida-Gomez T., Rendal-Vazquez M.E., Fuentes-Boquete I., de Toro F.J., Blanco F.J. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J. Cell. Biochem. 2010, 111:846-857.
28. Dmitrieva R.I., Minullina I.R., Bilibina A.A., Tarasova O.V., Anisimov S.V., Zaritskey A.Y. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 2012, 11:377-383.
29. Dobreva M.P., Pereira P.N., Deprest J., Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int. J. Dev. Biol. 2010, 54:761-777.
30. Dolgin E. Gene flaw found in induced stem cells. Nature 2010, 464:663.
31. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
32. Erlandsson A., Lin C.H., Yu F., Morshead C.M. Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury. Exp. Neurol. 2011, 230:48-57.
33. Fan Y., Chong Y.S., Choolani M.A., Cregan M.D., Chan J.K. Unravelling the mystery of stem/progenitor cells in human breast milk. PLoS One 2011, 5:e14421.
34. Fazekasova H., Lechler R., Langford K., Lombardi G. Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs. J. Tissue Eng. Regen. Med. 2011, 5:684-694.
35. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., Zhang S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4335-4340.
36. Huang H., Chen L., Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 2010, 1:15-46.
37. Jandial R., Snyder E.Y. A safer stem cell: on guard against cancer. Nat. Med. 2009, 15:999-1001.
38. Jansen B.J., Gilissen C., Roelofs H., Schaap-Oziemlak A., Veltman J.A., Raymakers R.A., Jansen J.H., Kogler G., Figdor C.G., Torensma R., Adema G.J. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev. 2010, 19:481-490.
39. Jiang M., Lv L., Ji H., Yang X., Zhu W., Cai L., Gu X., Chai C., Huang S., Sun J., Dong Q. Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Mol. Cell. Biochem. 2011, 354:67-75.
40. Jin K., Mao X., Xie L., Galvan V., Lai B., Wang Y., Gorostiza O., Wang X., Greenberg D.A. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J. Cereb. Blood Flow Metab. 2010, 30:534-544.
41. Jin K., Xie L., Mao X., Greenberg M.B., Moore A., Peng B., Greenberg R.B., Greenberg D.A. Effect of human neural precursor cell transplantation on endogenous neurogenesis after focal cerebral ischemia in the rat. Brain Res. 2011, 1374:56-62.
42. Kanematsu D., Shofuda T., Yamamoto A., Ban C., Ueda T., Yamasaki M., Kanemura Y. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation 2011, 82:77-88.
43. Karaoz E., Demircan P.C., Saglam O., Aksoy A., Kaymaz F., Duruksu G. Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells. Histochem. Cell Biol. 2011, 136:455-473.
44. Kim J.M., Lee S.T., Chu K., Jung K.H., Song E.C., Kim S.J., Sinn D.I., Kim J.H., Park D.K., Kang K.M., Hyung Hong N., Park H.K., Won C.H., Kim K.H., Kim M., Kun Lee S., Roh J.K. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 2007, 1183:43-50.
45. Kim S.H., Kim Y.S., Lee S.Y., Kim K.H., Lee Y.M., Kim W.K., Lee Y.K. Gene expression profile in mesenchymal stem cells derived from dental tissues and bone marrow. J. Periodontal Implant Sci. 2011, 41:192-200.
46. Kojima T., Hirota Y., Ema M., Takahashi S., Miyoshi I., Okano H., Sawamoto K. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells 2010, 28:545-554.
47. Koketsu D., Furuichi Y., Maeda M., Matsuoka N., Miyamoto Y., Hisatsune T. Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia. Exp. Neurol. 2006, 199:92-102.
48. Kondziolka D., Steinberg G.K., Wechsler L., Meltzer C.C., Elder E., Gebel J., Decesare S., Jovin T., Zafonte R., Lebowitz J., Flickinger J.C., Tong D., Marks M.P., Jamieson C., Luu D., Bell-Stephens T., Teraoka J. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J. Neurosurg. 2005, 103:38-45.
49. Konig J., Huppertz B., Desoye G., Parolini O., Frohlich J.D., Weiss G., Dohr G., Sedlmayr P., Lang I. Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells. Stem Cells Dev. 2011, 21:1309-1320.
50. Lee J.M., Jung J., Lee H.J., Cho K.J., Hwang S.G., Kim G.J. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int. Immunopharmacol. 2012, 13:219-224.
51. Leu S., Lin Y.C., Yuen C.M., Yen C.H., Kao Y.H., Sun C.K., Yip H.K. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J. Transl. Med. 2010, 8:63.
52. Lin R.Z., Moreno-Luna R., Zhou B., Pu W.T., Melero-Martin J.M. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis 2012, 15:443-455.
53. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., Downes M., Yu R., Stewart R., Ren B., Thomson J.A., Evans R.M., Ecker J.R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
54. Liu X.S., Chopp M., Zhang R.L., Hozeska-Solgot A., Gregg S.C., Buller B., Lu M., Zhang Z.G. Angiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke. J. Biol. Chem. 2009, 284:22680-22689.
55. Liu X.S., Chopp M., Zhang R.L., Tao T., Wang X.L., Kassis H., Hozeska-Solgot A., Zhang L., Chen C., Zhang Z.G. MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS One 2011, 6:e23461.
56. MacIsaac Z.M., Shang H., Agrawal H., Yang N., Parker A., Katz A.J. Long-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cells. Exp. Cell Res. 2012, 318:416-423.
57. Mack G.S. ReNeuron and StemCells get green light for neural stem cell trials. Nat. Biotechnol. 2011, 29:95-97.
58. Marcus A.J., Woodbury D. Fetal stem cells from extra-embryonic tissues: do not discard. J. Cell. Mol. Med. 2008, 12:730-742.
59. Matsuda R., Yoshikawa M., Kimura H., Ouji Y., Nakase H., Nishimura F., Nonaka J., Toriumi H., Yamada S., Nishiofuku M., Moriya K., Ishizaka S., Nakamura M., Sakaki T. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant. 2009, 18:39-54.
60. McGregor J.A., Rogo L.J. Breast milk: an unappreciated source of stem cells. J. Hum. Lact. 2006, 22:270-271.
61. Meng X., Ichim T.E., Zhong J., Rogers A., Yin Z., Jackson J., Wang H., Ge W., Bogin V., Chan K.W., Thebaud B., Riordan N.H. Endometrial regenerative cells: a novel stem cell population. J. Transl. Med. 2007, 5:57.
62. Minger S.L., Ekonomou A., Carta E.M., Chinoy A., Perry R.H., Ballard C.G. Endogenous neurogenesis in the human brain following cerebral infarction. Regen. Med. 2007, 2:69-74.
63. Minnerup J., Kim J.B., Schmidt A., Diederich K., Bauer H., Schilling M., Strecker J.K., Ringelstein E.B., Sommer C., Scholer H.R., Schabitz W.R. Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Stroke 2011, 42:1757-1763.
64. Miura M., Gronthos S., Zhao M., Lu B., Fisher L.W., Robey P.G., Shi S. SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5807-5812.
65. Najar M., Raicevic G., Boufker H.I., Fayyad-Kazan H., De Bruyn C., Meuleman N., Bron D., Toungouz M., Lagneaux L. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng. Part A 2010, 16:3537-3546.
66. Nakagomi N., Nakagomi T., Kubo S., Nakano-Doi A., Saino O., Takata M., Yoshikawa H., Stern D.M., Matsuyama T., Taguchi A. Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction. Stem Cells 2009, 27:2185-2195.
67. Nakayama D., Matsuyama T., Ishibashi-Ueda H., Nakagomi T., Kasahara Y., Hirose H., Kikuchi-Taura A., Stern D.M., Mori H., Taguchi A. Injury-induced neural stem/progenitor cells in post-stroke human cerebral cortex. Eur. J. Neurosci. 2010, 31:90-98.
68. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15:213-223.
69. Newman M.B., Misiuta I., Willing A.E., Zigova T., Karl R.C., Borlongan C.V., Sanberg P.R. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. 2005, 14:29-43.
70. Newman M.B., Willing A.E., Manresa J.J., Davis-Sanberg C., Sanberg P.R. Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev. 2005, 14:576-586.
71. Newman M.B., Willing A.E., Manresa J.J., Sanberg C.D., Sanberg P.R. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp. Neurol. 2006, 199:201-208.
72. Nygren J., Wieloch T., Pesic J., Brundin P., Deierborg T. Enriched environment attenuates cell genesis in subventricular zone after focal ischemia in mice and decreases migration of newborn cells to the striatum. Stroke 2006, 37:2824-2829.
73. Oh J.S., Kim K.N., An S.S., Pennant W.A., Kim H.J., Gwak S.J., Yoon do H., Lim M.H., Choi B.H., Ha Y. Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model. Cell Transplant. 2011, 20:837-849.
74. Ohi Y., Qin H., Hong C., Blouin L., Polo J.M., Guo T., Qi Z., Downey S.L., Manos P.D., Rossi D.J., Yu J., Hebrok M., Hochedlinger K., Costello J.F., Song J.S., Ramalho-Santos M. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 2011, 13:541-549.
75. Park D.H., Eve D.J., Musso J., Klasko S.K., Cruz E., Borlongan C.V., Sanberg P.R. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells Dev. 2009, 18:693-702.
76. Park D.H., Eve D.J., Sanberg P.R., Musso J., Bachstetter A.D., Wolfson A., Schlunk A., Baradez M.O., Sinden J.D., Gemma C. Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation. Stem Cells Dev. 2010, 19:175-180.
77. Patel A.N., Park E., Kuzman M., Benetti F., Silva F.J., Allickson J.G. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant. 2008, 17:303-311.
78. Pollock K., Stroemer P., Patel S., Stevanato L., Hope A., Miljan E., Dong Z., Hodges H., Price J., Sinden J.D. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol. 2006, 199:143-155.
79. Ra J.C., Shin I.S., Kim S.H., Kang S.K., Kang B.C., Lee H.Y., Kim Y.J., Jo J.Y., Yoon E.J., Choi H.J., Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011, 20:1297-1308.
80. Rodrigues M.C., Voltarelli J., Sanberg P.R., Allickson J.G., Kuzmin-Nichols N., Garbuzova-Davis S., Borlongan C.V. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neurosci. Biobehav. Rev. 2012, 36:177-190.
81. Rubio D., Garcia-Castro J., Martin M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., Bernad A. Spontaneous human adult stem cell transformation. Cancer Res. 2005, 65:3035-3039.
82. Sabapathy V., Ravi S., Srivastava V., Srivastava A., Kumar S. Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int. 2012, 2012:174328.
83. Saino O., Taguchi A., Nakagomi T., Nakano-Doi A., Kashiwamura S., Doe N., Nakagomi N., Soma T., Yoshikawa H., Stern D.M., Okamura H., Matsuyama T. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J. Neurosci. Res. 2010, 88:2385-2397.
84. Sanberg P.R., Eve D.J., Cruz L.E., Borlongan C.V. Neurological disorders and the potential role for stem cells as a therapy. Br. Med. Bull. 2012, 101:163-181.
85. Sanberg P.R., Eve D.J., Willing A.E., Garbuzova-Davis S., Tan J., Sanberg C.D., Allickson J.G., Cruz L.E., Borlongan C.V. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant. 2011, 20:85-94.
86. Sanberg P.R., Garbuzova-Davis S., Tan J., Eve D.J., Borlongan C.V., Cruz L.E., Kuzmin-Nichols N., Sanberg C.D. Human umbilical cord blood cells for neurodegenerative diseases: importance of lower dose multiple injections. Cell Transplant. 2012, 21:788.
87. Sgubin D., Aztiria E., Perin A., Longatti P., Leanza G. Activation of endogenous neural stem cells in the adult human brain following subarachnoid hemorrhage. J. Neurosci. Res. 2007, 85:1647-1655.
88. Shi W., Nie D., Jin G., Chen W., Xia L., Wu X., Su X., Xu X., Ni L., Zhang X., Chen J. BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 2012, 33:3119-3126.
89. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009, 40:510-515.
90. Strioga M.M., Viswanathan S., Darinskas A., Slaby O., Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012, 21:2724-2752.
91. Subramanian A., Shu-Uin G., Kae-Siang N., Gauthaman K., Biswas A., Choolani M., Bongso A., Chui-Yee F. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells. J. Cell. Biochem. 2012, 113:1886-1895.
92. Tat P.A., Sumer H., Jones K.L., Upton K., Verma P.J. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant. 2010, 19:525-536.
93. Taupin P. Stroke-induced neurogenesis: physiopathology and mechanisms. Curr. Neurovasc. Res. 2006, 3:67-72.
94. Thored P., Wood J., Arvidsson A., Cammenga J., Kokaia Z., Lindvall O. Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 2007, 38:3032-3039.
95. Tolar J., Nauta A.J., Osborn M.J., Panoskaltsis Mortari A., McElmurry R.T., Bell S., Xia L., Zhou N., Riddle M., Schroeder T.M., Westendorf J.J., McIvor R.S., Hogendoorn P.C., Szuhai K., Oseth L., Hirsch B., Yant S.R., Kay M.A., Peister A., Prockop D.J., Fibbe W.E., Blazar B.R. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007, 25:371-379.
96. Tonchev A.B., Yamashima T., Sawamoto K., Okano H. Enhanced proliferation of progenitor cells in the subventricular zone and limited neuronal production in the striatum and neocortex of adult macaque monkeys after global cerebral ischemia. J. Neurosci. Res. 2005, 81:776-788.
97. van Velthoven C.T., Kavelaars A., van Bel F., Heijnen C.J. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav. Immun. 2010, 24:387-393.
98. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35:2390-2395.
99. Vendrame M., Gemma C., de Mesquita D., Collier L., Bickford P.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005, 14:595-604.
100. Vidal M.A., Walker N.J., Napoli E., Borjesson D.L. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells Dev. 2012, 21:273-283.
101. Vieira N.M., Brandalise V., Zucconi E., Secco M., Strauss B.E., Zatz M. Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant. 2010, 19:279-289.
102. Walczak P., Chen N., Eve D., Hudson J., Zigova T., Sanchez-Ramos J., Sanberg P.R., Sanberg C.D., Willing A.E. Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. Brain Res. Bull. 2007, 74:155-163.
103. White R.B. Looks like a duck, quacks like a duck ... still behaves like a bone marrow stromal cell. Transl. Res. 2011, 157:53-55.
104. Willing A.E., Eve D.J., Sanberg P.R. Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regen. Med. 2007, 2:457-464.
105. Willing A.E., Lixian J., Milliken M., Poulos S., Zigova T., Song S., Hart C., Sanchez-Ramos J., Sanberg P.R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 2003, 73:296-307.
106. Womble T.A., Green S.M., Nelson A.P., Shahaduzzaman M.D., Golden J.E., Sanberg P.R., Pennypacker K.R., Willing A.E. CD14+ and CD133+ human umbilical cord blood cells are essential for neurological recovery following MCAO. Cell Transplant. 2009, 18:240.
107. Wu W., He Q., Li X., Zhang X., Lu A., Ge R., Zhen H., Chang A.E., Li Q., Shen L. Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells. Int. J. Biol. Sci. 2011, 7:892-901.
108. Yang K.L., Chen M.F., Liao C.H., Pang C.Y., Lin P.Y. A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy. Cytotherapy 2009, 11:606-617.
109. Yarygin K.N., Kholodenko I.V., Konieva A.A., Burunova V.V., Tairova R.T., Gubsky L.V., Cheglakov I.B., Pirogov Y.A., Yarygin V.N., Skvortsova V.I. Mechanisms of positive effects of transplantation of human placental mesenchymal stem cells on recovery of rats after experimental ischemic stroke. Bull. Exp. Biol. Med. 2009, 148:862-868.
110. Yu J.M., Jun E.S., Bae Y.C., Jung J.S. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008, 17:463-473.
111. Yu S.J., Soncini M., Kaneko Y., Hess D.C., Parolini O., Borlongan C.V. Amnion: a potent graft source for cell therapy in stroke. Cell Transplant. 2009, 18:111-118.
112. Yust-Katz S., Fisher-Shoval Y., Barhum Y., Ben-Zur T., Barzilay R., Lev N., Hod M., Melamed E., Offen D. Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress. Cytotherapy 2012, 14:45-55.
113. Zhang R.L., Chopp M., Gregg S.R., Toh Y., Roberts C., Letourneau Y., Buller B., Jia L., Nejed Davarani S.P., Zhang Z.G. Patterns and dynamics of subventricular zone neuroblast migration in the ischemic striatum of the adult mouse. J. Cereb. Blood Flow Metab. 2009, 29:1240-1250.
114. Zhang W., Yan Q., Zeng Y.S., Zhang X.B., Xiong Y., Wang J.M., Chen S.J., Li Y., Bruce I.C., Wu W. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 2010, 1359:256-271.
115. Zhang Y., Bellows C.F., Kolonin M.G. Adipose tissue-derived progenitor cells and cancer. World J. Stem Cells 2010, 2:103-113.
116. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.